Cardioplegic strategies to protect the hypertrophic heart during cardiac surgery

Perfusion (United Kingdom) - Tập 26 Số 1_suppl - Trang 48-56 - 2011
M.Saadeh Suleiman1, Matthew Hancock1, Ratnesh K. Shukla1, Cha Rajakaruna1, Gianni D. Angelini1,2
1Bristol Heart Institute, Faculty of Medicine & Dentistry, University of Bristol, Bristol, UK
2Imperial College London, Hammersmith Hospital, London, UK

Tóm tắt

Cardioplegic arrest and cardiopulmonary bypass are key triggers of myocardial injury during aortic valve surgery. Cardioplegic ischaemic arrest is associated with disruption to metabolic and ionic homeostasis in cardiomyocytes. These changes predispose the heart to reperfusion injury caused by elevated intracellular reactive oxygen species and calcium. Cardiopulmonary bypass is associated with an inflammatory response that can generate systemic oxidative stress which, in turn, provokes further damage to the heart. Techniques of myocardial protection are routinely applied to all hearts, irrespective of their pathology, although different cardiomypathies respond differently to ischaemia and reperfusion injury. In particular, the efficacy of cardioprotective interventions used to protect the hypertrophic heart in patients with aortic valve disease remains controversial. This review will describe key cellular changes in hypertrophy, response to ischaemia and reperfusion and cardioplegic arrest and highlight the importance of optimising cardioprotective strategies to suit hypertrophic hearts.

Từ khóa


Tài liệu tham khảo

10.1038/sj.bjp.0707526

10.1016/S0163-7258(00)00102-9

10.1139/Y09-103

10.1016/j.bbabio.2007.05.008

10.1016/S0140-6736(55)93381-X

10.1007/s10863-009-9206-x

10.1152/ajpheart.01153.2004

10.1152/ajpcell.00270.2006

10.1111/j.1749-6632.2010.05627.x

10.1097/00005344-200309000-00008

10.1177/021849230501300422

10.1016/j.ejcts.2006.01.058

10.1016/j.freeradbiomed.2005.01.016

10.1016/j.cardiores.2003.10.011

10.2174/1568010033484098

10.1152/ajpendo.00278.2004

10.1161/01.CIR.99.3.427

10.1016/S0022-5223(98)70018-2

10.1067/mtc.2000.108168

10.1016/S0008-6363(98)00229-6

10.1023/A:1025498319598

10.1097/FJC.0b013e31802c0cd0

10.1191/0267659106pf861oa

Devereux RB, 1987, J Clin Hypertens, 3, 66

10.1093/eurheartj/13.suppl_D.2

10.1056/NEJM199210013271406

10.1016/j.hrthm.2008.12.021

10.1023/A:1015380609464

10.1172/JCI27374

10.1016/j.bbrc.2004.07.121

10.1016/S0092-8674(02)00861-9

10.1161/01.RES.83.4.345

10.1161/hh1101.091862

10.1038/nm805

10.1073/pnas.0405488102

10.1038/ncb1137

10.1172/JCI24497

10.1111/j.1749-6632.2009.05100.x

10.1097/HCO.0b013e328339f191

10.1016/0306-9877(95)90239-2

10.1161/01.CIR.97.17.1716

10.1006/jmcc.1998.0814

10.2337/diab.45.1.S59

10.1007/s00424-006-0096-z

Zhang Y, 1995, Chin Med J (Engl), 108, 28

10.1097/01.CCM.0000282085.63409.FB

10.1111/j.1748-1716.1994.tb09747.x

10.1081/CEH-200031822

10.1161/hc37t1.094851

10.1007/s10741-010-9180-8

10.1016/j.ejcts.2004.08.032

10.1113/jphysiol.2004.060616

10.1023/A:1006807510648

10.1510/icvts.2006.136317

Peng LY, 2006, Zhonghua Xin Xue Guan Bing Za Zhi., 34, 685

10.1016/S0003-4975(10)61275-1

10.1111/j.1540-8191.1996.tb00061.x

10.1161/01.CIR.92.9.155

Anderson WA, 1995, J Cardiovasc Surg (Torino)., 36, 17

10.1016/j.ejcts.2010.03.052

10.1016/j.jtcvs.2009.05.036

10.1016/S1010-7940(98)00247-4

10.2217/fca.10.102

Trunk P, 2010, J Heart Valve Dis, 19, 716

10.1111/j.1540-8191.2010.01000.x

10.1016/S0022-5223(19)35763-0

10.1111/j.1540-8191.2007.00536.x

10.1016/j.ejcts.2007.11.010

10.1093/cvr/cvn114

Ali N, 2010, J Coll Physicians Surg Pak, 20, 427

10.1136/hrt.2008.155770

10.1007/s00395-010-0104-5

10.1016/j.jss.2010.06.016

10.1590/S0102-76382008000300017

Onorati F, 2005, J Cardiovasc Surg (Torino), 46, 569

Takeuchi K, 2002, J Cardiovasc Surg (Torino), 43, 37

10.1161/01.CIR.93.9.1640

10.1053/stcs.2001.22740

10.1016/j.athoracsur.2008.12.016

Bahamondes SJ, 2008, Rev Med Chil, 136, 1141, 10.4067/S0034-98872008000900008